Development of the sulfur mustard resistant keratinocyte cell line HaCaT/SM

Annette Schmidt1, Dirk Steinritz2, Horst Thiermann3

  • 1Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstraße 11, 80937 Munich, Germany; Department of Molecular and Cellular Sports Medicine, German Sports University, Am Sportpark Müngersdorf 6, 50933 Cologne, Germany.

Toxicology Letters
|October 15, 2015
PubMed

Insights

Researchers developed the first sulfur mustard (SM) resistant keratinocyte cell line, HaCaT/SM, after over 40 months of continuous exposure. This new cell line offers a vital tool for studying SM resistance mechanisms and developing effective cancer treatments.

Area of Science:

  • Toxicology
  • Dermatology
  • Cancer Research

Background:

  • Cytotoxic drug-resistant cell lines are crucial for developing cancer treatment strategies.
  • Despite extensive research, a sulfur mustard (SM)-resistant keratinocyte cell line has not been previously established.

Purpose of the Study:

  • To develop the first sulfur mustard (SM)-resistant keratinocyte cell line.
  • To create a valuable tool for understanding SM resistance and informing therapeutic development.

Main Methods:

  • A sensitive HaCaT keratinocyte cell line was continuously exposed to gradually increasing concentrations of SM over 40 months.
  • The exposure strategy began with 0.07μM SM twice weekly, escalating to a final concentration of 7.2μM SM.

Main Results:

  • The developed cell line, HaCaT/SM, demonstrated a 4.7-fold increase in LC50 and an 8.2-fold increase in LC90 compared to the sensitive parent line.
  • HaCaT/SM cells tolerated SM concentrations that caused a 93% inhibitory effect in the original HaCaT cells.

Conclusions:

  • The successful development of the HaCaT/SM cell line represents a significant advancement in SM resistance research.
  • This novel cell line provides a unique platform for investigating SM-induced cellular responses and resistance mechanisms in keratinocytes.